Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition
NCT04756427Phase 4Terminated
- Sponsor
- Johns Hopkins University
- Start
- Mar 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trisodium citrate in central line-associated bloodstream infection (CLABSI), sponsored by Johns Hopkins University. Started Mar 2022; status: terminated.
02
Drugs
trisodium citrate
03
Conditions
central line-associated bloodstream infection (CLABSI)
Beyond the preview
Go deeper on NCT04756427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04756427.